Myeloablative haploidentical BMT with posttransplant cyclophosphamide for hematologic malignancies in children and adults

Promising results have been reported for patients with high-risk hematologic malignancies undergoing HLA-haploidentical bone marrow transplantation (haploBMT) with posttransplantation cyclophosphamide (PTCy), but there are few data on outcomes with myeloablative conditioning in this context. We repo...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Blood Adv
Main Authors: Symons, Heather J., Zahurak, Marianna, Cao, Yilin, Chen, Allen, Cooke, Kenneth, Gamper, Christopher, Klein, Orly, Llosa, Nicolas, Zambidis, Elias T., Ambinder, Richard, Bolaños-Meade, Javier, Borrello, Ivan, Brodsky, Robert, DeZern, Amy, Gojo, Ivana, Showel, Margaret, Swinnen, Lode, Smith, B. Douglas, Luznik, Leo, Jones, Richard J., Fuchs, Ephraim J.
Formato: Artigo
Idioma:Inglês
Publicado: American Society of Hematology 2020
Assuntos:
Clinical Trials and Observations
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7448587/
https://ncbi.nlm.nih.gov/pubmed/32813874
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020001648
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares